Small Pharma Ltd
9Patents
9Active
9Granted
60Portfolio score
Filing activity: Jul 31, 2018 → May 6, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11471417B2 | Deuterated N,N-dimethyltryptamine compounds | Chemistry; Metallurgy | 14 | Active |
| US11406619B2 | Injectable formulations | Human Necessities | 11 | Active |
| US11697638B2 | 5-methoxy-N,N-dimethyltryptamine crystalline forms | Chemistry; Metallurgy | 9 | Active |
| US11660289B2 | Deuterated or partially deuterated N,N-dimethyltryptamine compounds | Chemistry; Metallurgy | 9 | Active |
| US11578039B2 | Compounds | Chemistry; Metallurgy | 8 | Active |
| US11643390B2 | Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses | Chemistry; Metallurgy | 8 | Active |
| US11773062B2 | Deuterated compounds | Chemistry; Metallurgy | 8 | Active |
| US11771681B2 | Therapeutic compounds | Chemistry; Metallurgy | 1 | Active |
| US11377416B2 | Crystalline forms of hydroxynorketamine | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.